403 related articles for article (PubMed ID: 33736962)
1. Metabolic Reprogramming in Anticancer Drug Resistance: A Focus on Amino Acids.
Pranzini E; Pardella E; Paoli P; Fendt SM; Taddei ML
Trends Cancer; 2021 Aug; 7(8):682-699. PubMed ID: 33736962
[TBL] [Abstract][Full Text] [Related]
2. Amino Acid Metabolism in Cancer Drug Resistance.
Yoo HC; Han JM
Cells; 2022 Jan; 11(1):. PubMed ID: 35011702
[TBL] [Abstract][Full Text] [Related]
3. Insights into new mechanisms and models of cancer stem cell multidrug resistance.
Garcia-Mayea Y; Mir C; Masson F; Paciucci R; LLeonart ME
Semin Cancer Biol; 2020 Feb; 60():166-180. PubMed ID: 31369817
[TBL] [Abstract][Full Text] [Related]
4. Mitochondria and cancer chemoresistance.
Guerra F; Arbini AA; Moro L
Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
[TBL] [Abstract][Full Text] [Related]
5. Stem cell programs in cancer initiation, progression, and therapy resistance.
Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
[TBL] [Abstract][Full Text] [Related]
6. Biological role of metabolic reprogramming of cancer cells during epithelial‑mesenchymal transition (Review).
Li M; Bu X; Cai B; Liang P; Li K; Qu X; Shen L
Oncol Rep; 2019 Feb; 41(2):727-741. PubMed ID: 30483813
[TBL] [Abstract][Full Text] [Related]
7. Targeting Metabolism in Cancer Cells and the Tumour Microenvironment for Cancer Therapy.
Li J; Eu JQ; Kong LR; Wang L; Lim YC; Goh BC; Wong ALA
Molecules; 2020 Oct; 25(20):. PubMed ID: 33092283
[TBL] [Abstract][Full Text] [Related]
8. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Shapira A; Livney YD; Broxterman HJ; Assaraf YG
Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
[TBL] [Abstract][Full Text] [Related]
9. Targeting autophagy in cancer stem cells as an anticancer therapy.
Lei Y; Zhang D; Yu J; Dong H; Zhang J; Yang S
Cancer Lett; 2017 May; 393():33-39. PubMed ID: 28216370
[TBL] [Abstract][Full Text] [Related]
10. Targeting Mitochondrial Function to Treat Quiescent Tumor Cells in Solid Tumors.
Zhang X; de Milito A; Olofsson MH; Gullbo J; D'Arcy P; Linder S
Int J Mol Sci; 2015 Nov; 16(11):27313-26. PubMed ID: 26580606
[TBL] [Abstract][Full Text] [Related]
11. Metabolic reprogramming: the emerging concept and associated therapeutic strategies.
Yoshida GJ
J Exp Clin Cancer Res; 2015 Oct; 34():111. PubMed ID: 26445347
[TBL] [Abstract][Full Text] [Related]
12. Cancer stem cell metabolism: a potential target for cancer therapy.
Deshmukh A; Deshpande K; Arfuso F; Newsholme P; Dharmarajan A
Mol Cancer; 2016 Nov; 15(1):69. PubMed ID: 27825361
[TBL] [Abstract][Full Text] [Related]
13. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
[TBL] [Abstract][Full Text] [Related]
14. Targeting Oxidative Phosphorylation Reverses Drug Resistance in Cancer Cells by Blocking Autophagy Recycling.
Lee JS; Lee H; Jang H; Woo SM; Park JB; Lee SH; Kang JH; Kim HY; Song J; Kim SY
Cells; 2020 Sep; 9(9):. PubMed ID: 32883024
[TBL] [Abstract][Full Text] [Related]
15. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
Dzobo K
OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
[TBL] [Abstract][Full Text] [Related]
16. Evaluating therapeutic efficacy against cancer stem cells: new challenges posed by a new paradigm.
Wang JC
Cell Stem Cell; 2007 Nov; 1(5):497-501. PubMed ID: 18938746
[TBL] [Abstract][Full Text] [Related]
17. Targeting cancer stem cells to suppress acquired chemotherapy resistance.
Vidal SJ; Rodriguez-Bravo V; Galsky M; Cordon-Cardo C; Domingo-Domenech J
Oncogene; 2014 Sep; 33(36):4451-63. PubMed ID: 24096485
[TBL] [Abstract][Full Text] [Related]
18. Dietary Phytochemicals as a Potential Source for Targeting Cancer Stem Cells.
Manogaran P; Umapathy D; Karthikeyan M; Venkatachalam K; Singaravelu A
Cancer Invest; 2021 Apr; 39(4):349-368. PubMed ID: 33688788
[TBL] [Abstract][Full Text] [Related]
19. Cancer stem cell (CSC) resistance drivers.
Najafi M; Mortezaee K; Majidpoor J
Life Sci; 2019 Oct; 234():116781. PubMed ID: 31430455
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma.
Issa ME; Takhsha FS; Chirumamilla CS; Perez-Novo C; Vanden Berghe W; Cuendet M
Clin Epigenetics; 2017; 9():17. PubMed ID: 28203307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
